XILAM ANIMATION (XIL.PA) Fundamental Analysis & Valuation

EPA:XIL • FR0004034072

Current stock price

3 EUR
-0.01 (-0.33%)
Last:

This XIL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. XIL.PA Profitability Analysis

1.1 Basic Checks

  • In the past year XIL has reported negative net income.
  • XIL had a positive operating cash flow in the past year.
  • XIL had positive earnings in 4 of the past 5 years.
  • In the past 5 years XIL always reported a positive cash flow from operatings.
XIL.PA Yearly Net Income VS EBIT VS OCF VS FCFXIL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

  • XIL has a worse Return On Assets (-27.66%) than 81.82% of its industry peers.
  • With a Return On Equity value of -51.39%, XIL is not doing good in the industry: 61.36% of the companies in the same industry are doing better.
  • XIL's Return On Invested Capital of 3.01% is fine compared to the rest of the industry. XIL outperforms 68.18% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for XIL is significantly below the industry average of 9.86%.
  • The 3 year average ROIC (2.87%) for XIL is below the current ROIC(3.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -27.66%
ROE -51.39%
ROIC 3.01%
ROA(3y)-7.65%
ROA(5y)-3.34%
ROE(3y)-13.96%
ROE(5y)-5.53%
ROIC(3y)2.87%
ROIC(5y)3.58%
XIL.PA Yearly ROA, ROE, ROICXIL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • XIL has a better Operating Margin (11.52%) than 75.00% of its industry peers.
  • XIL's Operating Margin has declined in the last couple of years.
  • The Gross Margin of XIL (94.47%) is better than 88.64% of its industry peers.
  • XIL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.52%
PM (TTM) N/A
GM 94.47%
OM growth 3Y-29.09%
OM growth 5Y-22.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y-0.8%
XIL.PA Yearly Profit, Operating, Gross MarginsXIL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

4

2. XIL.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XIL is destroying value.
  • XIL has more shares outstanding than it did 1 year ago.
  • XIL has more shares outstanding than it did 5 years ago.
  • XIL has a better debt/assets ratio than last year.
XIL.PA Yearly Shares OutstandingXIL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
XIL.PA Yearly Total Debt VS Total AssetsXIL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that XIL is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.32, XIL perfoms like the industry average, outperforming 56.82% of the companies in the same industry.
  • The Debt to FCF ratio of XIL is 1.23, which is an excellent value as it means it would take XIL, only 1.23 years of fcf income to pay off all of its debts.
  • XIL has a Debt to FCF ratio of 1.23. This is amongst the best in the industry. XIL outperforms 86.36% of its industry peers.
  • A Debt/Equity ratio of 0.11 indicates that XIL is not too dependend on debt financing.
  • XIL has a Debt to Equity ratio of 0.11. This is in the better half of the industry: XIL outperforms 79.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.23
Altman-Z 1.32
ROIC/WACC0.53
WACC5.66%
XIL.PA Yearly LT Debt VS Equity VS FCFXIL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • XIL has a Current Ratio of 0.93. This is a bad value and indicates that XIL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • XIL's Current ratio of 0.93 is in line compared to the rest of the industry. XIL outperforms 59.09% of its industry peers.
  • A Quick Ratio of 0.93 indicates that XIL may have some problems paying its short term obligations.
  • The Quick ratio of XIL (0.93) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.93
XIL.PA Yearly Current Assets VS Current LiabilitesXIL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. XIL.PA Growth Analysis

3.1 Past

  • XIL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -501.62%.
  • The Revenue for XIL has decreased by -40.87% in the past year. This is quite bad
  • The Revenue has been growing slightly by 1.01% on average over the past years.
EPS 1Y (TTM)-501.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-699.02%
Revenue 1Y (TTM)-40.87%
Revenue growth 3Y-4.45%
Revenue growth 5Y1.01%
Sales Q2Q%-44.84%

3.2 Future

  • XIL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.00% yearly.
  • XIL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.82% yearly.
EPS Next Y85.05%
EPS Next 2Y42.46%
EPS Next 3Y29%
EPS Next 5YN/A
Revenue Next Year-37.93%
Revenue Next 2Y-12.98%
Revenue Next 3Y-3.82%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XIL.PA Yearly Revenue VS EstimatesXIL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
XIL.PA Yearly EPS VS EstimatesXIL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

3

4. XIL.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for XIL. In the last year negative earnings were reported.
  • Also next year XIL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XIL.PA Price Earnings VS Forward Price EarningsXIL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • XIL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. XIL is cheaper than 100.00% of the companies in the same industry.
  • XIL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. XIL is cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.27
EV/EBITDA 0.44
XIL.PA Per share dataXIL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as XIL's earnings are expected to grow with 29.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.46%
EPS Next 3Y29%

0

5. XIL.PA Dividend Analysis

5.1 Amount

  • XIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

XIL.PA Fundamentals: All Metrics, Ratios and Statistics

XILAM ANIMATION

EPA:XIL (9/18/2025, 7:00:00 PM)

3

-0.01 (-0.33%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-16
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.67M
Revenue(TTM)23.49M
Net Income(TTM)-25.57M
Analysts48.89
Price Target3.37 (12.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.75
P/FCF 2.27
P/OCF 1.03
P/B 0.36
P/tB N/A
EV/EBITDA 0.44
EPS(TTM)-4.31
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)1.32
FCFY43.97%
OCF(TTM)2.92
OCFY97.25%
SpS3.99
BVpS8.45
TBVpS-1.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.66%
ROE -51.39%
ROCE 4.1%
ROIC 3.01%
ROICexc 3.39%
ROICexgc N/A
OM 11.52%
PM (TTM) N/A
GM 94.47%
FCFM 33.08%
ROA(3y)-7.65%
ROA(5y)-3.34%
ROE(3y)-13.96%
ROE(5y)-5.53%
ROIC(3y)2.87%
ROIC(5y)3.58%
ROICexc(3y)3.22%
ROICexc(5y)4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)4.89%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.11%
ROICexc growth 5Y-18.18%
OM growth 3Y-29.09%
OM growth 5Y-22.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y-0.8%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 1.23
Debt/EBITDA 0.13
Cap/Depr 22.39%
Cap/Sales 40.08%
Interest Coverage 4.67
Cash Conversion 38.39%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.93
Altman-Z 1.32
F-Score4
WACC5.66%
ROIC/WACC0.53
Cap/Depr(3y)71.92%
Cap/Depr(5y)106.47%
Cap/Sales(3y)53.47%
Cap/Sales(5y)81.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-501.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-699.02%
EPS Next Y85.05%
EPS Next 2Y42.46%
EPS Next 3Y29%
EPS Next 5YN/A
Revenue 1Y (TTM)-40.87%
Revenue growth 3Y-4.45%
Revenue growth 5Y1.01%
Sales Q2Q%-44.84%
Revenue Next Year-37.93%
Revenue Next 2Y-12.98%
Revenue Next 3Y-3.82%
Revenue Next 5YN/A
EBIT growth 1Y-45.03%
EBIT growth 3Y-32.24%
EBIT growth 5Y-21.22%
EBIT Next Year118.51%
EBIT Next 3Y35.15%
EBIT Next 5YN/A
FCF growth 1Y-35.26%
FCF growth 3YN/A
FCF growth 5Y6.64%
OCF growth 1Y-45.83%
OCF growth 3Y-11.63%
OCF growth 5Y-8.76%

XILAM ANIMATION / XIL.PA Fundamental Analysis FAQ

What is the fundamental rating for XIL stock?

ChartMill assigns a fundamental rating of 3 / 10 to XIL.PA.


What is the valuation status for XIL stock?

ChartMill assigns a valuation rating of 3 / 10 to XILAM ANIMATION (XIL.PA). This can be considered as Overvalued.


Can you provide the profitability details for XILAM ANIMATION?

XILAM ANIMATION (XIL.PA) has a profitability rating of 4 / 10.